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Abstract: Background U.S. healthcare spending will reach 20% of GDP by 2026. Despite this spending, almost 14% of our 
under-65 population still lacks health insurance and out-of-pocket healthcare spending is high. To date, much of the healthcare 
reform debate has focused on who pays—the government, employers or individuals. Objective To review current healthcare 
reform issues and evidence. Method We address the questions of how much we pay, how we pay and what we receive for the 
money as a potential foundation for constructive dialogue. Results U.S. healthcare spending continues to exceed that of other 
countries, without offering universal coverage. Notwithstanding coverage expansions implemented under the Affordable Care 
Act, uninsurance rates have been rising. Rapid growth of high deductible plans has also significantly increased rates of 
underinsurance. There is very little evidence that specific policies or interventions employed to date will significantly reduce cost, 
especially under a fee for service system, where volume makes up for cuts. Global risk payments hold the greatest promise for 
real cost containment because they can drive true delivery system reform. Conclusion Meaningful, long-term healthcare reform 
cannot be successful until comprehensive, evidence-based policies that address healthcare costs are fully embraced and 
implemented. 
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1. Introduction 
U.S. healthcare spending will reach 20% of GDP by 2026 
[1]. Despite this spending, almost 14% of the U.S. under-65 
population still lack health insurance [2]. Because 
out-of-pocket costs for healthcare are high and continue to go 
up, an increasing number of insured Americans are having 
difficulty accessing comprehensive care. The plight of those 
who lack insurance (uninsured) and those who lack adequate 
insurance (underinsured) cannot be ignored. 
To date, much of the healthcare reform debate in the U.S. 
has focused on who pays—the government, employers or 
individuals. Ultimately, the American people pay in one way 
or the other: through taxes, paycheck deductions, benefits in 
lieu of wages, or straight out of pocket. The real questions 
should not be who pays but should be how much can the 
American public can afford to pay, how they pay and what 
they receive for the money. Healthcare reform will not be 
successful in the U.S. until comprehensive, evidence-based 
policies are fully embraced and implemented. The root causes 
of the American health system’s problems must be clearly 
articulated, openly and publicly debated and addressed in 
order to develop a rational delivery model rather than one that 
just rations care. 
2. Skyrocketing Costs: Implications and 
Consequences 
In the U.S., the Medicaid program is funded jointly between 
state and federal governments to provide coverage for 
low-income populations. Medicaid accounted for 19.6% of 
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spending from state general funds in 2016, more than doubling 
since 1990 (9.6%) [3]. States that adopted Medicaid expansion 
under the Affordable Care Act (ACA) are particularly 
challenged since they now must cover the full 10% of 
expansion costs. Since most states cannot carry deficits from 
year to year because of balance budget requirements, they are 
forced to either raise more money (taxes) or cut spending 
somewhere else. This fiscal reality has forced state lawmakers 
to make some very painful decisions, and state-level 
healthcare reform may be the frontline in generating effective 
models for a restructured healthcare delivery system. 
The U.S. federal government is not immune to the fiscal 
pain of high healthcare spending. The federal government 
spent nearly $1.1 trillion on health care in fiscal year 2018 
(27% of the federal budget) [4]. Since employer and 
employee health insurance contributions are exempt from 
federal taxes, the government lost an additional $280 billion 
per year in tax revenue. The U.S. federal deficit now exceeds 
a trillion dollars and is projected to grow; this level of 
spending will ultimately demand healthcare spending cuts. 
Despite these massive financial commitments, the health 
status of Americans lags behind that of citizens in many other 
advanced countries, even though these countries spend 
substantially less on healthcare. For example, the U.S. ranks 
24th in infant mortality and 28th in life expectancy at birth, 
falling behind most European countries [5]. Interestingly, 
countries with better health statistics tend to spend 
considerably more on social programs that address poverty 
and the social determinants of health (SDOHs), such as food 
security, housing adequacy, and education [6]. In fact, total 
spending on all social programs including healthcare is 
comparable between the U.S. and other countries with better 
health outcomes. Our spending approach just does not yield 
the bang for the buck in terms of health outcomes. 
The impact of healthcare spending on the competitiveness 
of U.S. companies is also significant. Employer-sponsored 
(family) health insurance premiums rose more than 50% 
between 2008 ($12,680) and 2018 ($19,616) [7]. Since 
employers currently pay about 72% of premiums, healthcare 
costs translate into reduced profits for U.S. companies. Warren 
Buffett described healthcare as “…a hungry tapeworm eating 
away at American companies” [8]. Many companies have 
responded by shifting healthcare costs to their employees. In 
2018, covered workers contributed, on average, 18% of the 
premium for single coverage and 29% for family coverage. 
Between 2006 and 2016, deductibles rose from an average of 
$303 to over $1,200. High deductible plans have become 
commonplace, covering 44% of adults ages 18-64 in 2017 and 
the percentage is projected to increase. Some companies, 
especially small (3-24 employees) and medium size firms 
(25-199), have simply stopped offering health insurance to 
their employees. In 2018, only 57% of U.S. companies offered 
health insurance to their employees, down from a high of 69% 
in 2010. Many American companies have also shifted jobs 
outside the U.S. to take advantage of lower compensation 
costs, including low or zero healthcare costs. 
Current healthcare costs also make healthcare unaffordable 
for millions of Americans and result in significant health 
disparities. In 2017, personal healthcare expenditures 
averaged $9,106 per person in the U.S., or roughly $36,424 for 
a family of four [9]. Comparing this amount to the U.S. federal 
poverty line [10] for this family size ($24,600) and the median 
household income ($61,400) for 2017, the challenge becomes 
clear: most U.S. families cannot afford healthcare on their own. 
One in five working-age Americans with health insurance still 
reported problems paying medical bills in the past year, 
according to a Kaiser Family Foundation/New York Times 
survey [11]. Medical expenses have become a significant 
source of personal bankruptcy. Concerns over healthcare costs 
have become a middle-class issue and not just a problem of the 
poor. 
Why does the U.S. spend so much money on healthcare? 
The most obvious culprit is the U.S. fee for service (FFS) 
payment system. There is simply no incentive to reduce 
utilization. In fact, quite the opposite: do more, get more. This 
incentive for volume can subliminally impact the behavior of 
even the most ethical, dedicated providers. The FFS payment 
system must be totally replaced by a reimbursement system 
that rewards efficiency and quality-value. A revised 
reimbursement system will drive the development of new 
delivery models that ensure access to high value care, focused 
on improving and preserving health and discouraging 
low-value care. 
Part of the American over-utilization also stems from 
cultural attitudes and patient demand for access and choice 
engendered by the era of indemnity coverage when insurance 
paid for almost all services regardless of price and known 
efficacy. Many view unfettered access to healthcare as a right 
and reject the concept that healthcare is a critical public 
commodity that must be effectively and efficiently managed 
for the benefit of all. Until recently, U.S. insurance plans 
offered low copays, deductibles and out-of-pocket maximums, 
giving patients little financial incentive to curb unfettered use. 
Politicians have either directly or indirectly reinforced the 
demand for choice. During the debate about Obamacare, both 
parties promised that “no one should get between you and 
your doctor”. 
But some experts say that the U.S. spending on healthcare is 
a lot less about volume and waste and a lot more about prices. 
In a 2003 Health Affairs article, a group of economists showed 
that, aside from a few high-tech services, Americans actually 
use less healthcare than residents of other industrialized 
countries: fewer hospital days and fewer physician office 
visits [12]. U.S. high healthcare spending is actually the result 
of much higher prices. For example, a recent study from 
Kaiser Family Foundation found that the average price of an 
angioplasty was $31,620 in the U.S.--far higher than Australia 
($11,164), Switzerland ($10,066) or the U.K. ($7,264) [13]. 
Similarly, C-section deliveries cost an average of $16,106 in 
the U.S., compared to $9,965 in Switzerland and $7,901 in 
Australia. 
The bottom line is that U.S. healthcare costs continue to 
spiral out of control. The rapid growth of high deductible and 
catastrophic plans means that individuals with insurance pay 
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more out of pocket for less comprehensive coverage, 
potentially adversely impacting their health and healthcare. 
Measures of the health of the U.S. population lag behind other 
developed countries who spend less on healthcare but more on 
social programs that address poverty and SDOHs. It is hard to 
imagine that the U.S. can begin to address the critical issues of 
health disparities, underlying SDOHs, and universal coverage 
without reining in healthcare costs. 
3. What We Have Learned About 
Healthcare Cost Containment 
Historically, healthcare payers and policies have targeted 
healthcare prices by using standardized fee schedules, limiting 
price growth rates, and encouraging use of cheaper goods (e.g. 
generic medications) and services (physician office rather than 
emergency room). The results have been disappointing. In 
1992, Medicare changed physician payments from a percent 
of billed charges to standardized fee schedules based on 
expected resources used. In subsequent years (1993-98), while 
fees remained relatively controlled, volume and intensity of 
physician services increased more than 30%, resulting in an 
overall increase in spending for physician services [14]. In 
1997, the Balanced Budget Act (BBA) established a 
sustainable growth rate (SGR) which tied increases in total 
physician payments to real, per-capita gross domestic product 
(GDP). This global budget cap was ultimately unsuccessful 
when the U.S. Congress repeatedly delayed implementation of 
necessary cuts to physician payments, and ultimately ditched 
the program because of immense political pressure from 
providers. Simply put, price controls in the U.S. have not 
worked. 
3.1. Prescription Drugs 
Americans spent an estimated $360 billion on prescription 
drugs in 2019 (about 9.5% of all healthcare expenditures), and 
these costs are projected to grow at a rate of 4-6% per year for 
the foreseeable future [15]. To control costs, most payers 
strongly incentivize patients to select generics or accept 
therapeutic substitution (using chemically different drugs with 
same expected clinical effect). While generic and therapeutic 
substitution target drug prices, they do not address overall 
drug utilization. The recent onslaught of direct-to-consumer 
marketing of expensive pharmaceuticals and biologicals will 
tend to countermand and offset price control efforts. Even if 
the U.S. could bring prescription drug spending in line with 
Canada (about a 30% reduction in per capita drug spending- a 
daunting challenge), this would only reduce national health 
expenditures by about 3% [16]. Reducing spending on 
pharmaceuticals and biologicals, which has received much 
attention in the U.S. Congress, is an important incremental 
step but does not solve the U.S. healthcare cost problem. 
Viewing drug costs as a critical tool to support population 
health should force providers to use them judiciously, relying 
on evidence-based formularies, alongside disease 
management protocols and pathways where available. 
3.2. Administrative Simplification 
Administrative simplification has been espoused by many 
as a cost saving opportunity. The estimated annual cost to U.S. 
physician practices for interacting with health plans is $31 
billion or about 14% of total collections [17]. Hospital 
administrative costs accounted for 25% of U.S. hospital 
expenditures ($215 billion in 2011), far higher than any other 
country [18]. In addition, average insurer administrative costs 
are estimated at 12.4% of premiums [19]. Unfortunately, there 
is limited evidence that simplification efforts implemented in 
recent rounds of U.S. healthcare reform have reduced 
administrative costs [20]. On the contrary, some recent cost 
containment efforts have actually increased the complexity 
and costs of gathering and reporting of appropriate data. FFS 
payment creates an enormous amount of administration that 
will remain until we move to simplified payment models (i.e. 
full risk) and metrics that matter. 
3.3. Healthcare Fraud and Abuse 
Healthcare fraud is knowingly deceiving someone or 
misrepresenting information in order to receive payment, 
while abuse involves provision of services that are 
inconsistent with accepted medical, business or fiscal 
practices. The National Health Care Anti-Fraud 
Association estimates that health care fraud and abuse costs 
the U.S. 3-10% of its’ healthcare spending ($68 - $230 
billion annually) [21]. Under the ACA, the U.S. federal 
government significantly ramped up their fraud and abuse 
operations, collecting about $2.4 billion in health care fraud 
judgments and settlements in 2017. While this is a 
substantial number, it still represents a very small fraction 
(0.3%) of current Medicare spending ($706 billion in 2017). 
Having a reimbursement system that does not reward 
volume, will go a long way in minimizing fraud and abuse. 
3.4. Medical Malpractice 
Medical malpractice in the U.S., including settlements, 
legal and administrative costs and defensive medicine, costs 
between $55.6 - $200 billion annually (2.4% – 10% of health 
spending). Ample evidence also indicates that the U.S. tort 
system does not compensate all patients equitably, [22] 
rapidly or efficiently [23] and may hamper efforts to improve 
patient safety [24] and lead to unnecessary tests and 
procedures [25]. To date, the data suggests that tort reforms 
have had an extremely limited impact on medical malpractice 
payments and overall healthcare costs [26]. 
3.5. Provider Risk 
Shifting risk to providers has shown some promise for cost 
control. In the 1980s Health Maintenance Organizations 
(HMOs) used restricted provider panels, capitated payments 
(per member per month), and organized care protocols for cost 
control. Subsequently, HMOs lost popularity and became less 
effective in their cost containment efforts for two reasons. 
First, primary care physicians with responsibility for 
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managing a patient’s overall care were initially referred to as 
“gatekeepers” rather than “patient advocates”. This very 
unfortunate label reinforced the lingering public concern that 
HMOs were focused on limiting choice and services to save 
money, rather than providing effective, cost efficient and 
comprehensive care. Second, state and federal courts undercut 
HMO cost control through a series of rulings, forcing them to 
pay for member use of non-HMO providers (see, for example, 
Moran v. Rush Prudential HMO). Even more devastating was 
the U.S. Supreme Court decision to uphold “any willing 
provider laws”, reinforcing the entitlement mentality of 
enrollees. 
In today’s U.S. marketplace, payers have moved beyond 
simple capitation, to a system that combines global payments 
with financial incentives for patient access, quality of care, 
and health outcomes. In addition, use of better data systems 
and risk-adjustment models to account for the health of 
covered lives arguably generates more equitable payments 
than those in the 1980s and 1990s. The overall cost savings 
that can be expected with full-risk global payment systems is 
still unknown. An evaluation of capitated Medicaid managed 
care programs noted cost savings ranging from 2 – 19% 
compared to Medicaid FFS, mainly due to reduced inpatient 
care [27]. Research recently published in the New England 
Journal of Medicine demonstrated that global budget 
contracts with quality incentives can ultimately drive 
significant cost savings (5.9 – 9.1% of average costs) and 
quality improvement, but gains may take several years to be 
realized [28]. 
Because many providers are too small to assume substantial 
financial risk, Medicare has pursued more limited pay for 
performance (P4P) programs. Hospitals currently pay 
substantial penalties for hospital acquired conditions (HACs) 
and unplanned readmissions under Medicare’s hospital P4P 
programs (close to $1 billion in 2017). Physicians also face 
financial incentives to improve quality and lower costs under 
the Medicare Access and CHIP Reauthorization Act of 2015 
(MACRA) [29]. Unfortunately, P4P imposes modest revenue 
decreases that can generally be offset by increased volume and 
‘careful coding’. Arguably, with full alignment of incentives, 
providers can be more engaged in meaningfully addressing 
quality and cost. 
3.6. Larger Risk Pools 
Larger risk pools create efficiencies and share risk among a 
larger group of beneficiaries. Authors of the ACA recognized 
that risk pooling could provide significant cost savings, 
mandating state-level health insurance exchanges to pool risk. 
To prevent adverse selection, where only the sickest enrollees 
end up in the pool, the ACA also included an individual 
mandate, requiring everyone to carry health insurance. 
Eliminating the individual mandate jeopardizes the ability of 
exchanges to control premiums. While many argue that it is 
unfair to require Americans to purchase health insurance, car 
insurance is compulsory in most states [30], and we would 
argue that most who don’t purchase health insurance are 
counting on someone else (e.g. hospitals and/or Medicaid) to 
pick up the bill if they have a significant health crisis or illness, 
requiring expensive care. 
Examining the range of strategies available to federal and 
state policymakers, we see very little evidence that specific 
policies or interventions will significantly reduce cost, 
especially under our FFS system, where volume makes up for 
cuts. Global risk payments hold the greatest promise for real 
cost containment because they can drive true delivery system 
reform. 
4. Health Insurance Coverage Is Moving 
in the Wrong Direction 
Recent attempts to control healthcare insurance costs have 
resulted in the rapid proliferation of high deductible health 
plans (HDHPs) and the introduction of “skinny plans”, 
shifting risk to consumers and leaving an increasing number 
of insured Americans financially vulnerable. In addition, even 
after the ACA, 13.7% of adults still lack health insurance (Q4 
2018), and these numbers are once again climbing. The rapid 
growth of the underinsured and the recent uptick in the 
uninsured is alarming many and has led to the “Medicare for 
All” movement. 
4.1. Underinsurance and Uninsured 
Since 2007, enrollment in high-deductible health plans 
(HDHPs) among employed adults age 18-64 has skyrocketed 
(from 5% to 30%) and continues to rise [31]. HDHPs are 
popular because their premiums are much lower than 
traditional plans, but that ‘affordability’ is driven by limited 
(“narrow”) provider networks and high deductibles (e.g. 
$2000 - $5000/year). 
HDHPs seek to engage individuals and make them smart 
consumers. As demonstrated by the classic Rand Health 
Insurance Experiment study, however, individuals with high 
out-of-pocket costs are likely to forego high value care that 
improves and preserves health, not just discretionary low 
value services [32]. High deductibles may also be a significant 
challenge for low-income individuals. So – most of the 
millions of low-income Americans who gain coverage 
through the ACA marketplaces are part of the growing 
underinsured population in our country, placing them at risk 
for foregoing necessary medical care or facing medical 
bankruptcy. Individuals with chronic conditions, even those 
with higher incomes, may also forego important medications 
and healthcare prior to meeting their deductible making this a 
middle class (and above) issue. 
HDHPs also raise concerns about the wisdom of placing so 
much decision-making responsibility on patients. Enrollees 
are bombarded with data profiling provider costs and quality 
and offering diagnostic and therapeutic options. A recent 
comparison of hospital ratings from four different sources 
found that only 10% of the 844 hospitals rated as high 
performers by one rating system were rated as a high 
performer by the other rating systems [33]. It is little wonder 
that consumers find it difficult to incorporate these data in 
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their decision-making. 
4.2. Uninsured 
While the ACA dramatically increased coverage between 
2010 and 2017, many individuals still lack health insurance, 
and uninsurance is once again on the rise [2]. The Supreme 
Court’s decision to allow states to opt out of Medicaid (2012) 
and the Trump Administration’s decision to offer a wide range 
of exemptions from individual mandate penalties (2018) and 
lowering penalties to $0 (2019) have weakened the impact of 
the ACA on coverage. 
Presently there are 37 million uninsured in the U.S. and 
increasing [34]. Most are U.S. citizens (80%), from childless 
households (66.6%), between the ages of 18 and 49 (64.5%) 
and working (82.4%). Many have incomes below 200% of 
the federal poverty line (57%) and reside in states that did not 
expanded Medicaid (50.8%). About 25% of the currently 
uninsured are eligible for Medicaid, and another 10.4% are 
eligible for a marketplace plan with generous subsidies. This 
means many uninsured have not “opted in” for various 
reasons and should be targeted. Better Medicaid recruitment 
and retention methods could substantially increase coverage 
rates. It is also likely that additional states participating in 
Medicaid expansion will also have a beneficial impact on 
coverage rates. 
5. Principles That Should Define a Future 
Healthcare System 
Clearly the U.S. healthcare system is faltering. The cost of 
healthcare as a percentage of GDP continues to increase. U.S. 
healthcare costs are unsustainable. At the same time the 
number of uninsured and underinsured are substantial and 
rising. The debate over U.S. healthcare reform has been too 
narrow and predominantly driven by politics and ideology. It 
needs to be expanded, focusing on the questions of how much 
Americans pay (and can afford), how they pay (to drive 
change) and what they get. From our review of policy and data 
we have defined ten principles that should govern 
comprehensive reform of the U.S. healthcare system. 
Principle 1. Universal or near-universal coverage. The cry 
for “Medicare for All” is really about increasing concerns over 
access to comprehensive and affordable care, rather than 
Medicare itself. This is as much about the underinsured as it is 
about the uninsured. 
Universal coverage will certainly rectify our moral 
dilemma about healthcare being a human right. Expanding the 
risk pool will also potentially moderate rate increases for 
purchasers of insurance. 
Principle 2. Comprehensive coverage of high value care. 
Access to and coverage of high value care, which improves 
and preserves health must be available to all. This can be 
achieved and facilitated through a standard benefit package, 
with modest deductibles and co-pays. Excessive out-of-pocket 
costs that discourage use of high value care are 
counterproductive. Low income individuals and people with 
chronic illnesses should have their out-of-pocket costs 
minimized, subsidized or even waived. 
Principle 3. Enhanced benefits purchased with post-tax 
dollars. Individuals should be able to, at their own expense 
using post tax dollars, purchase additional benefits beyond 
those offered in the standard benefit package. Some would 
argue that this leads to tiered healthcare. We would argue that 
the U.S. already has 4 tiers: uninsured, under-insured, 
adequately insured and luxuriously insured (growing segment 
of concierge medicine). We would prefer 2 tiers: adequately 
insured and those who wish to purchase even more benefits. 
Principle 4. Provider and patient engagement and support. 
Without widespread support from both providers and patients, 
significant change will fail. Physicians must assume 
responsibility for and take pride in a delivery system that 
provides effective, affordable, and equitable healthcare. 
Appropriate reimbursement systems for Medicare, Medicaid 
and other government sponsored health insurance plans can be 
a potent mechanism for engaging physicians. Likewise, 
consumers must recognize that effective, affordable, equitable 
healthcare is a critical public commodity that must be managed 
for the benefit of all. Some choice, particularly choice of plan, 
must be preserved; however, unfettered access that reflects the 
entitlement of the indemnity era cannot be supported. 
Principle 5. Global payments with appropriate risk 
adjustment are necessary. Our current fee-for-service system 
incentivizes ‘do more, get more’, rather than emphasizing 
what matters: outcomes, cost, and patient care experience. 
Global payments, by shifting risk to plans and providers, 
encourages innovation and should catalyze changes in our 
healthcare delivery model, focusing efforts on efficiency, 
quality and satisfaction. One way that global budgets can be 
achieved is through vouchers or per capita payments. 
Vouchers might be purchased by individuals who receive 
additional pay in lieu of healthcare benefits; employers might 
offer vouchers as a healthcare benefit; Medicare and Medicaid 
might be administered through a voucher system; and the 
federal government could subsidize vouchers for low income 
individuals. Vouchers must fully cover the basic benefit 
package (Principle #2). To adequately compensate for 
variation in enrollee health, appropriate risk adjustment needs 
to be used. Risk adjusting global payments (vouchers) will 
level the playing field: discouraging providers and plans from 
cherry-picking patients associated with more generous 
premium margins (premium minus cost) and adequately 
compensating those who serve high-needs patients (such as 
those with challenging social determinants of health). A 
voucher system does not necessarily disrupt our current 
insurance system. Vouchers could be used to purchase 
coverage through insurance companies or purchase coverage 
directly from a provider system or network. 
Principle 6. Provider incentives for efficient, effective and 
patient-centered care. Alternative payment models that not 
only offer global payments with appropriate risk adjustment, 
but also include direct incentives for quality, access and 
outcomes, can catalyze changes in our delivery system, 
pressing for value and minimizing nonproductive and futile 
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care. These models of payment should also encourage 
providers to manage and minimize administrative costs and 
discourage fraud and abuse. Aggressive competition among 
providers based on quality, patient satisfaction and access is 
necessary and essential to assure consumers that providers are 
not skimping on care. Providers will understand and respond 
much better to clear and direct incentives rather than 
overwhelmingly burdensome regulations. 
Principle 7. Healthcare system consolidation must be 
allowed and supported. Large integrated networks and 
systems can provide comprehensive, coordinated and 
integrated services, align incentives to drive efficiency, safety, 
quality and satisfaction, serve sufficient numbers to manage 
risk, and be geographically dispersed to offer easy access. 
Consolidation combined with quality and price competition, 
what Enthoven called managed competition [35], creates 
countervailing market power on both purchaser and supplier 
sides that can support cost control, improved health outcomes 
and patient-centered care. Such entities are not just theoretical. 
Kaiser-Permanente, Geisinger Health, and Intermountain 
Health, among others, serve large defined populations and 
have demonstrated that they can deliver value, quality and 
efficiency. The Department of Justice is often opposed to 
consolidation because of presumed impact on prices. It may be 
true that consolidation under FFS often results in increased 
prices; this is not necessarily the case with global payments. 
Principle 8. Clear information and consumer choice. 
Consumers should be offered clear, concise and easily 
understandable data, along with incentives that encourage 
sound choice among competing plans, based on quality, 
accessibility and satisfaction. In addition, performance 
measures should be adequately adjusted for patient complexity, 
so that consumers can make fair comparisons of providers. 
State and Federal governments can and should impose some 
licensing requirements on plans and require timely reporting 
of consumer-centric information. 
Principle 9. Investment in evidence-based health system 
innovation. We need to know more about what works and does 
not work in our health system both clinically and organizationally. 
We spend a tremendous amount of money to develop treatments 
and programs, but relatively little to understand their 
dissemination, implementation and impact in the populations we 
serve. We desperately need to develop strong evidence on what 
works and use that evidence to drive further innovation. 
Principle 10. Responsible and realistic cost control. Global 
budgets can bend the cost curve effectively, but this must be 
done gradually enough to avoid major disruptions to access 
and quality of care. Providers need time to construct and 
mature appropriate information systems and delivery models. 
We need to set an acceptable, achievable target for healthcare 
expenditures as a percentage of GDP and a timeline for 
achieving this cost control that is not pushed off course by 
special interest lobbying efforts. Reaching this target can free 
up much-needed dollars for other investments; federal and 
state governments will be able to fund other high-priority 
projects like education and infrastructure, while employers 
can re-invest in their companies and/or their employees to 
enhance their competitive positions. Most importantly, if 
healthcare costs are sufficiently reined in, we as a country can 
put more focus on health and the Social Determinants of 
Health and not just healthcare. 
6. Conclusions 
None of the principles we outline are new and unique. 
Together, however, they provide strategic direction for the 
changes our healthcare delivery system desperately needs. Not 
adhering to these principles will doom reform efforts. We 
must understand and accept that our healthcare system is 
deteriorating, and incremental change will not suffice. 
Comprehensive change will be difficult and incur opposition. 
As a nation, we must muster the political courage to get the job 
done. The cost of inaction is too high. 
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